Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
International Immunopharmacology|July 22, 2025
Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cellsJing Zhang, Guoxuan Xie, Jun Yang, et al.
Signal Transduction and Targeted Therapy|February 3, 2026
Cyclic di-GMP suppresses cancer metastasis by targeting proteasome 26S subunit non-ATPase 3 independently of STINGJieqiong Wang, Alexander Mrozek, Kewen Hu, et al.
Journal of Nanobiotechnology|September 2, 2025
Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma modelYufei Wu, Gongrui Sun, Wendan Ren, et al.
Pharmacological Research|November 15, 2017
Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approachesZengrui Wu, Weiqiang Lu, Weiwei Yu, et al.
Plos One|January 10, 2013
A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cellsFujun Dai, Yihua Chen, Yajuan Song, et al.
Nucleic Acids Research|November 14, 2014
PubAngioGen: a database and knowledge for angiogenesis and related diseasesPeng Li, Yongrui Liu, Huan Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 30, 2022
YYFZBJS inhibits colorectal tumorigenesis by enhancing Tregs-induced immunosuppression through HIF-1α mediated hypoxia in vivo and in vitroYuli Zhang, Ni Chai, Zhenzhen Wei, et al.
Carcinogenesis|August 25, 2010
Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathwayYanmin Dong, Binbin Lu, Xiaoli Zhang, et al.
Journal of Medicinal Chemistry|January 3, 2020
Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of <i>N</i>-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor GrowthWeikai Guo, Yajing Xing, Qiansen Zhang, et al.
Biochemical Pharmacology|April 6, 2020
The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinasesXia Qin, Longmiao Hu, Shen-Nan Shi, et al.
Pageof 7